The cross-talk between FTH1 & PYCR1 plays a pivotal role in driving the progression of KRAS-mutated pancreatic cancer

被引:0
|
作者
Park, Jimin [1 ]
Qiu, Yuankai [1 ,2 ]
Su, Yenhao [3 ,4 ,5 ]
Chen, Hsinan [3 ,4 ,5 ]
Lee, Alanyueh L. [6 ]
Chang, Jungsu [1 ]
Kuo, Chengchin [7 ]
Chiu, Chingfeng [2 ,8 ,9 ]
机构
[1] TMU, Coll Nutr, Sch Nutr & Hlth Sci, Taipei, Taiwan
[2] TMU, Coll Nutr, Grad Inst Metab & Obes Sci, Taipei, Taiwan
[3] TMU, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[4] TMU, Shuang Ho Hosp, Div Gen Surg, Taipei, Taiwan
[5] TMU, Sch Med, Dept Surg, Taipei, Taiwan
[6] NHRI, Natl Inst Canc Res, Taipei, Taiwan
[7] NHRI, Inst Cell & Syst Med, Taipei, Taiwan
[8] TMU, Nutr Res Ctr, Taipei, Taiwan
[9] TMU, Res Ctr Canc Translat Med, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-2046
引用
收藏
页码:1289 / 1289
页数:1
相关论文
共 14 条
  • [1] The cross-talk between FTH1 and PYCR1 drives pancreatic cancer progression.
    Park, Ji Min
    Chiu, Ching-Feng
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells
    Park, Ji Min
    Su, Yen-Hao
    Fan, Chi-Shuan
    Chen, Hsin-Hua
    Qiu, Yuan-Kai
    Chen, Li-Li
    Chen, Hsin-An
    Ramasamy, Thamil Selvee
    Chang, Jung-Su
    Huang, Shih-Yi
    Chang, Wun-Shaing Wayne
    Lee, Alan Yueh-Luen
    Huang, Tze-Sing
    Kuo, Cheng-Chin
    Chiu, Ching-Feng
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (09): : 2065 - 2081
  • [3] Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells (vol 56, pg 2065, 2024)
    Park, Ji Min
    Su, Yen-Hao
    Fan, Chi-Shuan
    Chen, Hsin-Hua
    Qiu, Yuan-Kai
    Chen, Li-Li
    Chen, Hsin-An
    Ramasamy, Thamil Selvee
    Chang, Jung-Su
    Huang, Shih-Yi
    Chang, Wun-Shaing Wayne
    Lee, Alan Yueh-Luen
    Huang, Tze-Sing
    Kuo, Cheng-Chin
    Chiu, Ching-Feng
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, : 700 - 701
  • [4] The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
    Thuwajit, Chanitra
    Ferraresi, Alessandra
    Titone, Rossella
    Thuwajit, Peti
    Isidoro, Ciro
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (04) : 1235 - 1254
  • [5] Cross-talk between Phospho-STAT3 and PLCγ1 Plays a Critical Role in Colorectal Tumorigenesis
    Zhang, Peng
    Zhao, Yiqing
    Zhu, Xiaofeng
    Sedwick, David
    Zhang, Xiaodong
    Wang, Zhenghe
    MOLECULAR CANCER RESEARCH, 2011, 9 (10) : 1418 - 1428
  • [6] Targeting NDRG1 to inhibit bidirectional oncogenic cross-talk between pancreatic cancer and stroma
    Geleta, Bekesho
    Park, Kyung Chan
    Jansson, Patric J.
    Sahni, Sumit
    Apte, Minoti
    Richardson, Des
    Kovacevic, Zaklina
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 13 - 14
  • [7] Cross-talk between IKK2 and Notch promotes pancreatic cancer progression in mice through Hes1 mediated PPARγ inhibitio
    Maniati, E.
    Bossard, M.
    Cook, N.
    Candido, J.
    Emami-Shahri, N.
    Nedospasov, S.
    Balkwill, F.
    Tuveson, D.
    Hagemann, T.
    IMMUNOLOGY, 2011, 135 : 169 - 169
  • [8] ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
    Sebastiano, Matteo Rossi
    Pozzato, Chiara
    Saliakoura, Maria
    Yang, Zhang
    Peng, Ren-Wang
    Galie, Mirco
    Oberson, Kevin
    Simon, Hans-Uwe
    Karamitopoulou, Evanthia
    Konstantinidou, Georgia
    SCIENCE ADVANCES, 2020, 6 (44):
  • [9] Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma
    Geleta, Bekesho
    Park, Kyung Chan
    Jansson, Patric J.
    Sahni, Sumit
    Maleki, Sanaz
    Xu, Zhihong
    Murakami, Takashi
    Pajic, Marina
    Apte, Minoti, V
    Richardson, Des R.
    Kovacevic, Zaklina
    FASEB JOURNAL, 2021, 35 (02):
  • [10] Molecular cross-talk between retinoic acid and NOTCH1 signaling pathways: Role in triple negative breast cancer
    Paroni, G.
    Zanetti, A.
    Bolis, M.
    Vallerga, A.
    Troiani, M.
    Fratelli, M.
    Kurosaki, M.
    Terao, M.
    Garattini, E.
    CANCER RESEARCH, 2019, 79 (04)